Manhattan Street Capital Reg A+ Engagement AgreementWarrant Agreement • July 13th, 2021 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This agreement (this "Agreement") will confirm the arrangements under which FundAthena, Inc., DBA Manhattan Street Capital ("MSC") and Global Cancer Technology, a Nevada Corporation/LLC, and its present and future subsidiaries and any entity used thereby to facilitate the Financings contemplated hereby (collectively, the "Client"), to act as the Client's advisor in connection with a possible Financing (as defined below) and the Client's use of MSC's proprietary technology platform (the “MSC Platform").
AMENDMENT NO. 2 TO LICENSE AGREEMENT NO. 2017-03-0236 (THE “AGREEMENT”) BETWEEN GLOBAL CANCER TECHNOLOGY, INC. AND THE UNIVERSITY OF CALIFORNIA FOR CASE NOS. SD2013-199 AND SD2020-395 (SD2016-342 EXCLUDED STARTING AMENDMENT #2 DATE)License Agreement • July 13th, 2021 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This amendment (“Amendment #2”) is made by and between Global Cancer Technology, Inc. a Nevada corporation, having an address at 16776 Bernardo Center Dr., Suite 203, San Diego, CA 92128 (“LICENSEE”), and The Regents Of The University Of California, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), as represented by its San Diego campus having an address at University of California, San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UCSD”).
